Impact pipeline

program Indication Target identification Hit identification lead optimization preclinical annual market (2025) owned

Neuro I

Parkinson's

$ 8 Billion
images

Neuro II

Alzheimer's

$ 10.05 Billion
images

Amyloid I

Various

$ 5 Billion
images

Oncology I

Various

$ 100 Billion
images

Many more indications and targets in research!

To learn more about our scientific work go to Publications and Patents.